tepotinib
merck
['lung', 'tepotinib']
presented today at #asco23, tepotinib treatment in patients with met exon 14 skipping non small cell lung cancer: long-term follow-up of the vision phase 2 nonrandomized clinical trial, from . free to read online during the meeting 
JAMA #Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology.